No Detail Found!

Analysis of Famotidine in API and Formulation using UV and HPLC.

Author(s)
Sidra Khan Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Fatima Qamar Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Farya Zafar Faculty of Pharmacy, University of Karachi, Karachi, Pakistan
Huma Ali Herbion Pakistan (Pvt.) Ltd, Korangi Industrial Area, Karachi, Pakistan
Safila Naveed Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Ghulam Sarwer Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Khan Usmanghani Faculty of Pharmacy, Jinnah University for Women,Karachi, Pakistan; Herbion Pakistan (Pvt.) Ltd., Korangi Industrial Area, Karachi, Pakistan
M Tanweer Alam Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan
Amanullah Khan Drugs Testing Laboratory Quetta, Health Department Baluchistan, Quetta, Pakistan
Abstract
Famotidine is histamine-2 blocker. These H2 antagonists are competitor of histamine. Hydrochloric acid is secreted by the Parietal cells that are present in epithelial cells of stomach and stifle the secretion of acid. We have developed the Spectrophotometric technique for the analysis of Famotidine. A drug sample dissolved in water to make Famotidine solution. In the same way, different dilutions were made. Absorbance was measured at 265nm and the assay was performed at 5 different dilutions of 100ppm. Percent assay and regression equation was also obtained to calculate further availability of drug. A simple, efficient and least time-consuming method was validated by HPLC. Company Shimadzu LC 20AT model was used containing 150 mm column. Mobile phase having ratio of (80:20, v/v) methanol: water was used and pH was adjusted to 3.30. Analyte concentrations were determined at wavelength 265nm using a UV-detector. All analyses were carrying out at room temperature (25 ± 2C). Famotidine was separated in formulations in approx. 5.0 min, linear calibration curves were obtained at concentration range from 100-25ppm. 0.9998 of correlation coefficients with an average recovery above 99.91% was also detected. Also, retention time (Rt) recognition of analytes from different dosage forms shows the stability and specificity of the developed method.
Publication Details
Page(s) 50-55
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 5, Issue: 1, Year: 2017

Request the full text from PASTIC

References
AgrawalYK,ShivramchandraK,SinghGN,RaoBE, 1992.Spectrophotometric determination of famotidine in pharmaceutical preparations,J Pharm Biomed Anal 10 521 -3
ZuhriAZ,ShubietahRM,BadahGM, 1999.Extractionalspectrophotometric determination of famotidine in pharmaceutical formulations,J Pharm Biomed Anal 2 459 -65
1999.Simultaneous high-performance liquid chromatographic analysis for famotidine, ranitidine HCl, cimetidine, and nizatidine in commercial products,Drug Dev Ind Pharm 25 379 -85
2005.Development of a rapid HPLC method for determination of famotidine in human plasma using a monolithic column,J Pharm Biomed Anal 677 -80
2010.Simultaneous determination of metformin, cimetidine, famotidine, and ranitidine in human serum and dosage formulations using HPLC with UV detection,J Chromatogr Sci 48 721 -5
J PharmSci, 2006.Biowaivermonographs for immediate release solid oral dosage forms: Cimetidine, 95 974 -84
A.Goodman Gilman,McGraw-Hill, 2001., 10 1009 -
."Pepcid Side Effects & Drug Interactions", -
2008.,2008. Retrieved 07 -
HirataYasufumi, issued 1981.Yanagisawa Isao; Ishii Yoshio; Tsukamoto Shinichi; Itonoriki; Isomura Yasuo; Takeda Masaaki, "Guanidinothiazole compounds, process for preparation and gastric inhibiting compositions containing them", 08 -
2002."Sankyo Pharma",Skyscape Mediwire -
2009.,Archived from the original on February 23 -
Retrieved, ., 10 -
HowardJM,ChremosAN,CollenMJ,McArthurKE,ChernerJA,MatonPN,CiarleglioCA,CorneliusMJ,GardnerJD,JensenRT, 1985.Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome,Gastroenterology 88 1026 -33
0

Citations

0

Downloads

60

Views